Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Microextraction techniques improve hormone testing while being environmentally friendly.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.